ORXCF
ORIX CORP
$38.45
-5.46%
No data for this timeframe.
Vol
SEC Reports6
Recent Activity
Jun 3, 2026
SEC
ORIX Corporation filed a Form 6-K on June 3, 2026, reporting the status of its ongoing share repurchase program. During
6-K — Impact 5/10
May 26, 2026
SEC
ORIX Corporation filed a Form 6-K on May 26, 2026, to furnish the Notice and Information Materials for its 63rd Annual G
6-K — Impact 3/10
May 15, 2026
SEC
ORIX disclosed that Toshiba's FY2026 results included ¥2,277 billion in income related to Kioxia Holdings Corporation, w
6-K — Impact 6/10
Analyst Ratings
3Strong Buy
8Buy
5Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 4 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.5/10.
BULLISH
6-K
5/10
ORIX Corporation filed a Form 6-K on June 3, 2026, reporting the status of its ongoing share repurch
Jun 3, 2026
NEUTRAL
6-K
3/10
ORIX Corporation filed a Form 6-K on May 26, 2026, to furnish the Notice and Information Materials f
May 26, 2026
BULLISH
6-K
6/10
ORIX disclosed that Toshiba's FY2026 results included ¥2,277 billion in income related to Kioxia Hol
May 15, 2026
BULLISH
6-K
7/10
ORIX reported strong FY2026 results with revenue up 15.9% to ¥3.33 trillion and net income up 27.2%
May 11, 2026
BULLISH
6-K
8/10
ORIX Corporation announced the sale of its 100% stake in ORIX Bank Corporation to Daiwa Next Bank, L
Apr 27, 2026
NEUTRAL
6-K
4/10
ORIX Corporation announced a simplified absorption-type company split involving its subsidiary Tsuku
Apr 13, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 69% buy across 16 analysts — 3 strong buy, 8 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $900.0B | 17.1% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $900.0B | 13.1% | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3404.6B | 376.2% | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3528.7B | 3.6% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 8 | 5 | 0 | 0 | 69% | |
| May 1, 2026 | 3 | 8 | 5 | 0 | 0 | 69% | |
| Apr 1, 2026 | 3 | 8 | 5 | 0 | 0 | 69% | |
| Mar 1, 2026 | 3 | 8 | 5 | 0 | 0 | 69% | |
| Feb 1, 2026 | 3 | 8 | 5 | 0 | 0 | 69% | |
| Jan 1, 2026 | 3 | 7 | 5 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.